• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨密度作为肝细胞癌手术患者的一个风险因素。

Bone Mineral Density as a Risk Factor for Patients Undergoing Surgery for Hepatocellular Carcinoma.

作者信息

Miyachi Yosuke, Kaido Toshimi, Yao Siuan, Shirai Hisaya, Kobayashi Atsushi, Hamaguchi Yuhei, Kamo Naoko, Yagi Shintaro, Uemoto Shinji

机构信息

Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

出版信息

World J Surg. 2019 Mar;43(3):920-928. doi: 10.1007/s00268-018-4861-x.

DOI:10.1007/s00268-018-4861-x
PMID:30465085
Abstract

BACKGROUND

We have reported the impact of sarcopenia and body composition on patients undergoing hepatectomy for hepatocellular carcinoma (HCC). However, the impact of bone mineral density (BMD) on outcomes after hepatectomy for HCC and correlation with other parameters including sarcopenia are unclear.

METHODS

We retrospectively analyzed 465 patients who underwent primary hepatectomy for HCC between April 2005 and March 2015. We analyzed the plain CT images at the level of the eleventh thoracic vertebra with the region of interest and defined as preoperative BMD.

RESULTS

In this cohort, male (n = 367) and female (n = 98) patients showed significant heterogeneity in age, body composition markers, tumor factors, peri-operative parameters and so on. The median preoperative BMD in male and female patients was 155 and 139 HU, respectively (P = 0.005). BMD was negatively correlated with age in female (r = -0.590, P < 0.001) and intramuscular adipose tissue content in both male and female (r = -0.332 and -0.359, respectively, P < 0.001). For males, BMD < 160 HU was associated with worse cancer-specific survival post-hepatectomy (P = 0.015). In contrast, females were not (P = 0.135). For male patients, multivariate analysis identified low BMD as an independent risk factor for death (hazard ratio 1.720, 95% confidence interval 1.038-2.922, P = 0.035) after hepatectomy for HCC.

CONCLUSION

Preoperative low BMD was an independent risk factor for cancer-specific mortality after hepatectomy for HCC.

摘要

背景

我们已经报道了肌肉减少症和身体成分对肝细胞癌(HCC)肝切除患者的影响。然而,骨密度(BMD)对HCC肝切除术后结局的影响以及与包括肌肉减少症在内的其他参数的相关性尚不清楚。

方法

我们回顾性分析了2005年4月至2015年3月期间接受HCC初次肝切除术的465例患者。我们分析了第11胸椎水平的平扫CT图像,并划定感兴趣区域,将其定义为术前骨密度。

结果

在该队列中,男性(n = 367)和女性(n = 98)患者在年龄、身体成分指标、肿瘤因素、围手术期参数等方面存在显著异质性。男性和女性患者术前骨密度的中位数分别为155 HU和139 HU(P = 0.005)。骨密度与女性年龄呈负相关(r = -0.590,P < 0.001),与男性和女性的肌内脂肪组织含量均呈负相关(分别为r = -0.332和-0.359,P < 0.001)。对于男性,骨密度<160 HU与肝切除术后更差的癌症特异性生存率相关(P = 0.015)。相比之下,女性则不然(P = 0.135)。对于男性患者,多变量分析确定低骨密度是HCC肝切除术后死亡的独立危险因素(风险比1.720,95%置信区间1.038 - 2.922,P = 0.035)。

结论

术前低骨密度是HCC肝切除术后癌症特异性死亡的独立危险因素。

相似文献

1
Bone Mineral Density as a Risk Factor for Patients Undergoing Surgery for Hepatocellular Carcinoma.骨密度作为肝细胞癌手术患者的一个风险因素。
World J Surg. 2019 Mar;43(3):920-928. doi: 10.1007/s00268-018-4861-x.
2
Preoperative intramuscular adipose tissue content is a novel prognostic predictor after hepatectomy for hepatocellular carcinoma.术前肌内脂肪组织含量是肝细胞癌肝切除术后一种新的预后预测指标。
J Hepatobiliary Pancreat Sci. 2015 Jun;22(6):475-85. doi: 10.1002/jhbp.236. Epub 2015 Mar 5.
3
Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.肌少症性肥胖对肝细胞癌患者肝切除术后结局的影响。
Ann Surg. 2019 May;269(5):924-931. doi: 10.1097/SLA.0000000000002555.
4
Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients.骨密度可预测肝细胞癌肝移植受者的移植后生存率。
Liver Transpl. 2016 Aug;22(8):1092-8. doi: 10.1002/lt.24458. Epub 2016 Jun 29.
5
Impact of postoperative changes in sarcopenic factors on outcomes after hepatectomy for hepatocellular carcinoma.肝细胞癌肝切除术后肌肉减少症相关因素的变化对预后的影响。
J Hepatobiliary Pancreat Sci. 2016 Jan;23(1):57-64. doi: 10.1002/jhbp.302. Epub 2015 Dec 3.
6
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].[一种肝切除术后肝细胞癌的新预后评分系统]
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005.
7
Recurrent hepatocellular carcinoma and poorer overall survival in patients undergoing left-sided compared with right-sided partial hepatectomy.与接受右侧部分肝切除术的患者相比,接受左侧部分肝切除术的患者复发性肝细胞癌发生率更高,总体生存率更低。
J Clin Gastroenterol. 2015 Feb;49(2):158-64. doi: 10.1097/MCG.0000000000000144.
8
Sarcopenia Impacts on Short- and Long-term Results of Hepatectomy for Hepatocellular Carcinoma.肌肉减少症对肝癌肝切除术近期和远期结果的影响。
Ann Surg. 2015 Jun;261(6):1173-83. doi: 10.1097/SLA.0000000000000743.
9
Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.伴有门静脉癌栓的晚期肝细胞癌肝切除术后的生存率
World J Gastroenterol. 2015 Jan 7;21(1):246-53. doi: 10.3748/wjg.v21.i1.246.
10
Longterm prognosis after hepatic resection for small hepatocellular carcinoma.小肝细胞癌肝切除术后的长期预后
J Am Coll Surg. 2004 Mar;198(3):356-65. doi: 10.1016/j.jamcollsurg.2003.10.017.

引用本文的文献

1
Bone mineral density predicts survival in patients with hepatocellular carcinoma and portal vein tumor thrombosis.骨密度可预测肝细胞癌合并门静脉癌栓患者的生存率。
PLoS One. 2025 Aug 22;20(8):e0330336. doi: 10.1371/journal.pone.0330336. eCollection 2025.
2
Perioperative and Oncological Outcome in Patients Undergoing Curative-Intent Liver Resection for Cholangiocarcinoma in the Context of Osteopenia.骨质疏松背景下接受根治性肝切除术治疗胆管癌患者的围手术期及肿瘤学结局
Cancers (Basel). 2025 Jul 1;17(13):2213. doi: 10.3390/cancers17132213.
3
Clinical impact of low bone mineral density in patients with colorectal cancer liver metastasis undergoing hepatectomy.

本文引用的文献

1
Proposal for new selection criteria considering pre-transplant muscularity and visceral adiposity in living donor liver transplantation.提出新的选择标准,考虑活体肝移植前的肌肉质量和内脏脂肪。
J Cachexia Sarcopenia Muscle. 2018 Apr;9(2):246-254. doi: 10.1002/jcsm.12276. Epub 2018 Feb 17.
2
Hepatocellular Carcinoma with Macrovascular Invasion: Defining the Optimal Treatment Strategy.伴有大血管侵犯的肝细胞癌:确定最佳治疗策略
Liver Cancer. 2017 Nov;6(4):360-374. doi: 10.1159/000481315. Epub 2017 Oct 19.
3
Efficacy and Safety of Systemic Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis of Phase III Trials.
接受肝切除术的结直肠癌肝转移患者低骨密度的临床影响
PLoS One. 2025 Jun 23;20(6):e0324719. doi: 10.1371/journal.pone.0324719. eCollection 2025.
4
Predictive value of osteopenia as prognostic marker for survival and recurrence in patients with gastrointestinal cancers: a systematic review and meta-analysis.骨质减少作为胃肠道癌症患者生存和复发的预后标志物的预测价值:一项系统评价和荟萃分析。
Front Med (Lausanne). 2025 May 1;12:1527829. doi: 10.3389/fmed.2025.1527829. eCollection 2025.
5
The Incidence of Osteoporosis in Hepatocellular Carcinoma Patients Under 65: A Retrospective Cohort Study.65岁以下肝细胞癌患者骨质疏松症的发病率:一项回顾性队列研究
Cureus. 2025 Mar 12;17(3):e80490. doi: 10.7759/cureus.80490. eCollection 2025 Mar.
6
Osteosarcopenia as a Predictor of Histopathologic Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer: a Retrospective Cohort Study.骨肉减少作为食管癌新辅助放化疗组织病理学反应的预测指标:一项回顾性队列研究
Langenbecks Arch Surg. 2025 Mar 25;410(1):105. doi: 10.1007/s00423-025-03687-8.
7
Prognostic significance of osteosarcopenia in patients with stage IV gastric cancer undergoing conversion surgery.骨肉减少症对接受转化手术的IV期胃癌患者的预后意义。
Langenbecks Arch Surg. 2024 Dec 14;410(1):7. doi: 10.1007/s00423-024-03574-8.
8
Improved Osteoporosis Prediction in Breast Cancer Patients Using a Novel Semi-Foundational Model.使用新型半基础模型改善乳腺癌患者骨质疏松症预测
J Imaging Inform Med. 2024 Dec 2. doi: 10.1007/s10278-024-01337-x.
9
Prognostic impact of preoperative osteosarcopenia on esophageal cancer surgery outcomes: a retrospective analysis.术前骨质减少性肌肉减少症对食管癌手术结局的预后影响:一项回顾性分析
Esophagus. 2025 Jan;22(1):77-84. doi: 10.1007/s10388-024-01101-8. Epub 2024 Nov 28.
10
Combined Bone Mineral Density (BMD) and Monocyte-to-Lymphocyte Ratio (MLR) Predicts Recurrence and Prognosis in Hepatocellular Carcinoma Patients Following Liver Resection.联合骨密度(BMD)与单核细胞与淋巴细胞比值(MLR)可预测肝癌患者肝切除术后的复发及预后。
Risk Manag Healthc Policy. 2024 Nov 9;17:2741-2754. doi: 10.2147/RMHP.S473247. eCollection 2024.
晚期肝细胞癌全身治疗的疗效与安全性:一项III期试验的网状Meta分析
Liver Cancer. 2017 Nov;6(4):337-348. doi: 10.1159/000481314. Epub 2017 Oct 19.
4
Impact of muscle volume and muscle function decline in patients undergoing surgical resection for hepatocellular carcinoma.接受肝癌切除术的患者肌肉量和肌肉功能下降的影响。
J Gastroenterol Hepatol. 2018 Jun;33(6):1271-1276. doi: 10.1111/jgh.14058. Epub 2018 Jan 19.
5
Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.肌少症性肥胖对肝细胞癌患者肝切除术后结局的影响。
Ann Surg. 2019 May;269(5):924-931. doi: 10.1097/SLA.0000000000002555.
6
Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment.肝细胞癌:治疗指南与医学治疗
Liver Cancer. 2016 Nov;6(1):16-26. doi: 10.1159/000449343. Epub 2016 Nov 29.
7
Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients.骨密度可预测肝细胞癌肝移植受者的移植后生存率。
Liver Transpl. 2016 Aug;22(8):1092-8. doi: 10.1002/lt.24458. Epub 2016 Jun 29.
8
Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies.肝外胆管恶性肿瘤切除术后骨骼肌术前数量和质量对预后的影响。
Surgery. 2016 Mar;159(3):821-33. doi: 10.1016/j.surg.2015.08.047. Epub 2015 Oct 23.
9
Relationship between pre-sarcopenia, sarcopenia and bone mineral density in elderly men.老年男性中肌肉减少症前期、肌肉减少症与骨密度之间的关系。
Arch Endocrinol Metab. 2015 Feb;59(1):59-65. doi: 10.1590/2359-3997000000011.
10
Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer.术前骨骼肌质量和数量对胰腺癌切除术后生存的影响。
Surgery. 2015 Jun;157(6):1088-98. doi: 10.1016/j.surg.2015.02.002. Epub 2015 Mar 19.